840058 | Hydro Soy PC

L-α-phosphatidylcholine, hydrogenated (Soy)


Size SKU Packaging Price
25mg 840058P-25mg 840058P-25mg 1 x 25mg $85.75
200mg 840058P-200mg 840058P-200mg 1 x 200mg $172.00
500mg 840058P-500mg 840058P-500mg 1 x 500mg $330.00
1g 840058P-1g 840058P-1g 1 x 1g $540.00
Base Price: ${originalprice|money}
Custom Packaging: (${concentration} @$4.00/ea. + $100) ${custompackagingtotal|money}
Packaging: ${concentration}
Item Total: ${totalprice|money}
(Sales Tax may apply)
Please select an option above.
${sku} - ${concentration}

Hydro Soy PC

Hydro Soy PC

L-α-phosphatidylcholine, hydrogenated (Soy)

Light Sensitive
1 Years
Storage Temperature
CAS Number
CAS Registry Number is a Registered Trademark of the American Chemical Society
Formula Weight
Exact Mass

Vera-González N, Bailey-Hytholt CM, Langlois L, de Camargo Ribeiro F, de Souza Santos EL, Junqueira JC, Shukla A. Anidulafungin liposome nanoparticles exhibit antifungal activity against planktonic and biofilm Candida albicans. J Biomed Mater Res A. 2020 May 3. doi: 10.1002/jbm.a.36984. Epub ahead of print. PMID: 32363762.

PubMed ID: 32363762

Gaál A, Garay TM, Horváth I, Máthé D, Szöllősi D, Veres DS, Mbuotidem J, Kovács T, Tóvári J, Bergmann R, Streli C, Szakács G, Mihály J, Varga Z, Szoboszlai N. Development and In Vivo Application of a Water-Soluble Anticancer Copper Ionophore System Using a Temperature-Sensitive Liposome Formulation. Pharmaceutics. 2020 May 20;12(5):466. doi: 10.3390/pharmaceutics12050466. PMID: 32443790; PMCID: PMC7284829.

PubMed ID: 32443790

Dadwal A, Mishra N, Rawal RK, Narang RK. Development and characterisation of clobetasol propionate loaded Squarticles as a lipid nanocarrier for treatment of plaque psoriasis. J Microencapsul. 2020 Apr 23:1-14. doi: 10.1080/02652048.2020.1756970. Epub ahead of print. PMID: 32293928.

PubMed ID: 32293928

Mutlu-Agardan NB, Yilmaz S, Kaynak Onurdag F, Celebi N. Development of effective AmB/AmB-αCD complex double loaded liposomes using a factorial design for systemic fungal infection treatment. J Liposome Res. 2020 May 21:1-12. doi: 10.1080/08982104.2020.1755980. Epub ahead of print. PMID: 32290745.

PubMed ID: 32290745

Chen ZJ, Yang SC, Liu XL, Gao Y, Dong X, Lai X, Zhu MH, Feng HY, Zhu XD, Lu Q, Zhao M, Chen HZ, Lovell JF, Fang C. Nanobowl-Supported Liposomes Improve Drug Loading and Delivery. Nano Lett. 2020 May 20. doi: 10.1021/acs.nanolett.0c00495. Epub ahead of print. PMID: 32431154.

PubMed ID: 32431154

Weiss LE, Shalev Ezra Y, Goldberg S, Ferdman B, Adir O, Schroeder A, Alalouf O, Shechtman Y. Three-dimensional localization microscopy in live flowing cells. Nat Nanotechnol. 2020 Apr 20. doi: 10.1038/s41565-020-0662-0. Epub ahead of print. PMID: 32313220.

PubMed ID: 32313220

Karimi M, Gheybi F, Zamani P, Mashreghi M, Golmohammadzadeh S, Darban SA, Badiee A, Jaafari MR. Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study. Int J Pharm. 2020 Apr 30;580:119211. doi: 10.1016/j.ijpharm.2020.119211. Epub 2020 Mar 7. PMID: 32156530.

PubMed ID: 32156530

Gurung S, Khan F, Gunassekaran GR, Yoo JD, Poongkavithai Vadevoo SM, Permpoon U, Kim SH, Kim HJ, Kim IS, Han H, Park JH, Kim S, Lee B. Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression. Biomaterials. 2020 Jul;247:119984. doi: 10.1016/j.biomaterials.2020.119984. Epub 2020 Mar 20. PMID: 32278214.

PubMed ID: 32278214

Drabik D, Chodaczek G, Kraszewski S, Langner M. Mechanical Properties Determination of DMPC, DPPC, DSPC, and HSPC Solid-Ordered Bilayers. Langmuir. 2020 Mar 24. doi: 10.1021/acs.langmuir.0c00475. Epub ahead of print. PMID: 32176506.

PubMed ID: 32176506

Blazaki S, Pachis K, Tzatzarakis M, Tsilimbaris M, Antimisiaris SG. Novel Liposome Aggregate Platform (LAP) system for sustained retention of drugs in the posterior ocular segment following intravitreal injection. Int J Pharm. 2019 Dec 21;576:118987. doi: 10.1016/j.ijpharm.2019.118987. [Epub ahead of print]. PMID: 31870961.

PubMed ID: 31870961

Lin M, Guo W, Zhang Z, Zhou Y, Chen J, Wang T, Zhong X, Lu Y, Yang Q, Wei Q, Han M, Xu D, Gao J. Reduced Toxicity of Liposomal Nitrogen Mustard Prodrug Formulation Activated by an Intracellular ROS Feedback Mechanism in Hematological Neoplasm Models. Mol Pharm. 2019 Dec 27;10.1021/acs.molpharmaceut.9b00928. doi: 10.1021/acs.molpharmaceut.9b00928. [Epub ahead of print]. PMID: 31825633.

PubMed ID: 31825633

Weiss VU, Balantic K, Pittenauer E, Tripisciano C, Friedbacher G, Weber V, Marchetti-Deschmann M, Allmaier G. Nano electrospray differential mobility analysis based size-selection of liposomes and very-low density lipoprotein particles for offline hyphenation to MALDI mass spectrometry. J Pharm Biomed Anal. 2020 Feb 5;179:112998. doi: 10.1016/j.jpba.2019.112998. Epub 2019 Nov 18.

PubMed ID: 31780280

Naziris N, Saitta F, Chrysostomou V, Libera M, Trzebicka B, Fessas D, Pispas S, Demetzos C. pH-responsive chimeric liposomes: From nanotechnology to biological assessment. Int J Pharm. 2020 Jan 25;574:118849. doi: 10.1016/j.ijpharm.2019.118849. Epub 2019 Nov 20.

PubMed ID: 31759107

Zheng Z, Ji H, Zong W, Ran Q, Wang X, Yang X, Zhao Z, Yang C, Xiao Y. Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3. AMB Express. 2019 Sep 18;9(1):150. doi: 10.1186/s13568-019-0875-5.

PubMed ID: 31535232

Van Haute D, Jiang W, Mudalige T. Evaluation of size-based distribution of drug and excipient in amphotericin B liposomal formulation. Int J Pharm. 2019 Oct 5;569:118603. doi: 10.1016/j.ijpharm.2019.118603. Epub 2019 Aug 8.

PubMed ID: 31401296

Lim C, Kang JK, Won WR, Park JY, Han SM, Le TN, Kim JC, Her J, Shin Y, Oh KT. Co-delivery of D-(KLAKLAK)2 Peptide and Chlorin e6 using a Liposomal Complex for Synergistic Cancer Therapy. Pharmaceutics. 2019 Jun 21;11(6). pii: E293. doi: 10.3390/pharmaceutics11060293.

PubMed ID: 31234389

Giannakou C, Aimonen K, Bloois LV, Catalán J, Geertsma RE, Gremmer ER, de Jong WH, Keizers PH, Schwillens PL, Vandebriel RJ, Park MV. Sensitive method for endotoxin determination in nanomedicinal product samples. Nanomedicine (Lond). 2019 May;14(10):1231-1246. doi: 10.2217/nnm-2018-0339.

PubMed ID: 31124759

Korani M, Ghaffari S, Attar H, Mashreghi M, Jaafari MR. Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma. Nanomedicine. 2019 May 16;20:102013. doi: 10.1016/j.nano.2019.04.016. [Epub ahead of print]

PubMed ID: 31103736

Davis MS, Marrero-Berrios I, Perez XI, Rabolli CP, Radhakrishnan P, Manchikalapati D, Schianodicola J, Kamath H, Schloss RS, Yarmush J. Alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy. J Inflamm Res. 2019 Mar 12;12:87-97. doi: 10.2147/JIR.S192749. eCollection 2019.

PubMed ID: 30881083

Stefanick JF, Omstead DT, Kiziltepe T, Bilgicer B. Dual-receptor targeted strategy in nanoparticle design achieves tumor cell selectivity through cooperativity. Nanoscale. 2019 Mar 7;11(10):4414-4427. doi: 10.1039/c8nr09431d.

PubMed ID: 30801591

Lin TW, Chien Y, Lin YY, Wang ML, Yarmishyn AA, Yang YP, Hwang DK, Peng CH, Hsu CC, Chen SJ, Chien KH. Establishing Liposome-Immobilized Dexamethasone-Releasing PDMS Membrane for the Cultivation of Retinal Pigment Epithelial Cells and Suppression of Neovascularization. Int J Mol Sci. 2019 Jan 9;20(2). pii: E241. doi: 10.3390/ijms20020241.

PubMed ID: 30634448

Chen M, Song F, Liu Y, Tian J, Liu C, Li R, Zhang Q. A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer. Nanoscale. 2019 Mar 7;11(9):3814-3826. doi: 10.1039/c8nr06218h. Epub 2019 Jan 2.

PubMed ID: 30600823

This Natural Lipid is a mixture and the structure shown above is only representative of one possible structure present in the product. Refer to chart for average fatty acid distribution.